ArticleCurrent oncology (Toronto, Ont.)2026

Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination Therapy.

Susumu Maruta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.